{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:04:32Z","timestamp":1793318672446,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.seizure.2016.10.014","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T14:02:32Z","timestamp":1477058552000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":177,"special_numbering":"C","title":["From genotype to phenotype in Dravet disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Svetlana","family":"Gataullina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2016.10.014_bib0005","series-title":"Handbook of clinical neurology, vol. 111 (3rd series). Pediatric neurology part I","first-page":"627","article-title":"Dravet syndrome (Severe myoclonic epilepsy in infancy)","author":"Dravet","year":"2013"},{"key":"10.1016\/j.seizure.2016.10.014_bib0010","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","article-title":"De novo mutations in the sodium-channel gene SCN1A causes severe myoclonic epilepsy of infancy","volume":"68","author":"Claes","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.seizure.2016.10.014_bib0015","doi-asserted-by":"crossref","first-page":"e1310","DOI":"10.1542\/peds.2015-1807","article-title":"Incidence of Dravet syndrome in a US population","volume":"136","author":"Wu","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.seizure.2016.10.014_bib0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S1474-4422(10)70107-1","article-title":"Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study","volume":"9","author":"McIntosh","year":"2010","journal-title":"Lancet Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.seizure.2016.10.014_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1528-1167.2011.02996.x","article-title":"Electroencephalographic characteristics of Dravet syndrome","volume":"52","author":"Bureau","year":"2011","journal-title":"Epilepsia"},{"issue":"Pt. 8","key":"10.1016\/j.seizure.2016.10.014_bib0030","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/brain\/aws151","article-title":"Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome","volume":"135","author":"Brunklaus","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2016.10.014_bib0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.eplepsyres.2008.04.015","article-title":"An unexpected EEG course in Dravet syndrome","volume":"81","author":"Nabbout","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2016.10.014_bib0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1528-1167.2011.03311.x","article-title":"Acute encephalopathy in children with Dravet syndrome","volume":"53","author":"Okumura","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.10.014_bib0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1750-1172-8-176","article-title":"Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy","volume":"8","author":"Nabbout","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.seizure.2016.10.014_bib0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.eplepsyres.2013.03.012","article-title":"Cognitive decline in Dravet syndrome: is there a cerebellar role?","volume":"106","author":"Battaglia","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2016.10.014_bib0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.yebeh.2013.11.021","article-title":"Cognitive and adaptive evaluation of 21 consecutive patients with Dravet syndrome","volume":"31","author":"Villeneuve","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2016.10.014_bib0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/WNL.0000000000002859","article-title":"Motor neuropathy contributes to crouching in patients with Dravet syndrome","volume":"87","author":"Gitiaux","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2016.10.014_bib0065","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1212\/WNL.0000000000000521","article-title":"Antecollis and levodopa-responsive parkinsonism are late features of Dravet syndrome","volume":"82","author":"Fasano","year":"2014","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.seizure.2016.10.014_bib0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1528-1167.2011.03002.x","article-title":"Mortality in Dravet syndrome: search for risk factors in Japanese patients","volume":"52","author":"Sakauchi","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.10.014_bib0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yebeh.2013.07.015","article-title":"Transition and transfer from pediatric to adult health care in epilepsy: a families\u2019 survey on Dravet syndrome","volume":"29","author":"Kuchenbuch","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2016.10.014_bib0080","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/brain\/awr129","article-title":"Dravet syndrome as epileptic encephalopathy: evidence from long-term course and Neuropathology","volume":"134","author":"Catarino","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2016.10.014_bib0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.yebeh.2015.09.013","article-title":"Hallucinations and delusions are frequently reported in individuals with Dravet syndrome","volume":"52","author":"Martin","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2016.10.014_bib0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pediatrneurol.2003.10.012","article-title":"Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy","volume":"30","author":"Ceulemans","year":"2004","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2016.10.014_bib0095","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/epi.12256","article-title":"Dravet syndrome: new potential genetic modifiers, imaging abnormalities, and ictal findings","volume":"54","author":"Gaily","year":"2013","journal-title":"Epilepsia"},{"issue":"14","key":"10.1016\/j.seizure.2016.10.014_bib0100","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/WNL.0000000000000291","article-title":"GABRA1 and STXBP1: novel genetic causes of Dravet syndrome","volume":"82","author":"Carvill","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.seizure.2016.10.014_bib0105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ajhg.2013.09.017","article-title":"EuroEPINOMICS RES Consortium: de novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome","volume":"93","author":"Suls","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.seizure.2016.10.014_bib0110","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1212\/WNL.0000000000001305","article-title":"CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures","volume":"84","author":"Thomas","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.seizure.2016.10.014_bib0115","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/epi.13422","article-title":"SCN8A encephalopathy: research progress and prospects","volume":"57","author":"Meisler","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.10.014_bib0120","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1002\/j.1460-2075.1989.tb08534.x","article-title":"Differential regulation of three sodium channel messengers RNAs in the rat central nervous system during development","volume":"8","author":"Beckh","year":"1989","journal-title":"EMBO J"},{"key":"10.1016\/j.seizure.2016.10.014_bib0125","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1460-9568.2009.07011.x","article-title":"Excitation by GABA in the SCN reaches its time and place (commentary on Irwin & Allen)","volume":"30","author":"Wagner","year":"2009","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.seizure.2016.10.014_bib0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2015.02.016","article-title":"Sleep impairment and reduced interneuron excitability in a mouse model of Dravet syndrome","volume":"77","author":"Kalume","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.seizure.2016.10.014_bib0135","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1523\/JNEUROSCI.4243-05.2006","article-title":"Why does fever trigger febrile seizures? GABAA receptor gamma2 subunit mutations associated with idiopathic generalized epilepsies have temperature-dependent trafficking deficiencies","volume":"26","author":"Kang","year":"2006","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.seizure.2016.10.014_bib0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-3565(25)22407-7","article-title":"Chronic flurazepam treatment produces decreased efficacy of the benzodiazepine ligands and pentobarbital with gamma-aminobutyric acidA receptors in cortical neurons","volume":"270","author":"Hu","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"July","key":"10.1016\/j.seizure.2016.10.014_bib0145","article-title":"Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment","author":"Niquet","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.seizure.2016.10.014_bib0150","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/00000542-199710000-00024","article-title":"Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans","volume":"87","author":"Wada","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.seizure.2016.10.014_bib0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.smrv.2005.05.002","article-title":"Sleep function and synaptic homeostasis","volume":"10","author":"Tononi","year":"2006","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.seizure.2016.10.014_bib0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0013-4694(82)90067-0","article-title":"Participation of the cerebellum in the regulation of the sleep-wakefulness cycle. Results in cerebellectomized cats","volume":"53","author":"Cunchillos","year":"1982","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.seizure.2016.10.014_bib0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yebeh.2011.11.022","article-title":"SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome","volume":"23","author":"Bender","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2016.10.014_bib0170","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.resp.2013.06.026","article-title":"Sudden unexpected death in Dravet syndrome: respiratory and other physiological dysfunctions","volume":"189","author":"Kalume","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.seizure.2016.10.014_bib0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mcn.2008.06.008","article-title":"Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments","volume":"39","author":"Duflocq","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.seizure.2016.10.014_bib0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2010.12.037","article-title":"Interactions between modulators of the GABA(A) receptor: stiripentol and benzodiazepines","volume":"654","author":"Fisher","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.seizure.2016.10.014_bib0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2012.11.002","article-title":"Stiripentol is anticonvulsant by potentiating GABAergic transmission in a model of benzodiazepine-refractory status epilepticus","volume":"67","author":"Grosenbaugh","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.seizure.2016.10.014_bib0190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/dmcn.12593","article-title":"Lamotrigine can be beneficial in patients with Dravet syndrome","volume":"57","author":"Dalic","year":"2015","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.seizure.2016.10.014_bib0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.seizure.2008.02.009","article-title":"Acute hepatic injury in a child with Dravet syndrome: no protective effect of stiripentol","volume":"17","author":"Goorhuis","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2016.10.014_bib0200","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1111\/epi.13407","article-title":"Five-year extended follow-up status of 10 patients with Dravet syndrome treated with fenfluramine","volume":"57","author":"Ceulemans","year":"2016","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131116301820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131116301820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:48:57Z","timestamp":1761011337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131116301820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":40,"alternative-id":["S1059131116301820"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2016.10.014","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From genotype to phenotype in Dravet disease","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2016.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}